An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
TitlePatent citation index of international patent families granted in critical technology categories, by selected region, country, or economy of patent inventor: 2021
TitlePriority patent families granted in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleHighly cited patents in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–21
TitlePriority patent families granted in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleHighly cited patents in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–21
TitlePriority patent families granted in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–24
1Scientific field normalization of citations helps account for differences in citation practices from one scientific field to another. For example, one scientific field may have citation norms where authors generously cite existing work that a given article is building on, while another may only cite the most essential and influential work. Without normalization, the former scientific field in the preceding example may be overrepresented in the global top 1%, whereas the latter scientific field may have no articles in the global top 1%. This ensures proportionality with total output and highly cited output.
2The employment affiliation is voluntarily supplied by GitHub users in their profiles; as a result, the sector and agency are not listed for a notable share of developers. This incomplete coverage may affect the reliability of location and sector analyses, which should be regarded as experimental at this time. Please see the Technical Appendix for more information on the limitations of this data source.
3The designations of large companies (more than 500 employees), small companies (fewer than 500 employees), and startup companies in this section are designated by AUTM in its Licensing Survey. They differ from the size designations within business establishment surveys elsewhere in this report, including the Annual Business Survey.
4The number of licenses and license options executed by startups was not collected by AUTM after 2022.
7R&D-intensive manufacturing industries may engage in design, processes, or materials analyzed in the literature under several headings, including advanced manufacturing and intelligent manufacturing. Examples include additive or nano-based manufacturing and biotechnology and biomanufacturing. For additional information, see Brocal, Sebastián, and González (2019), IDA (2012), and PCAST (2020).
8See Thomas (2026) for comprehensive economic statistics on U.S. manufacturing.
9See the Glossary section for the definition of total private services used in this report.
TitleU.S. federal agency activity in granted patents, S&E articles, and articles cited by patents, by inventor's or author's affiliated agency: 2013–24
TitlePatent citation index of international patent families granted in critical technology categories, by selected region, country, or economy of patent inventor: 2021
TitlePriority patent families granted in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleHighly cited patents in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–21
TitlePriority patent families granted in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleHighly cited patents in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–21
TitlePriority patent families granted in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–24
TitleUSPTO utility patents granted in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–24
Highly cited patents granted in artificial intelligence, machine learning, autonomy, and related advances, by selected region, country, or economy: 2010 and 2021
Figure TRN-8Priority patent families granted in artificial intelligence, machine learning, autonomy, and related advances, for the world and China: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-9Utility patents granted in artificial intelligence, machine learning, autonomy, and related advances, by selected region, country, or economy: 2024ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-10Highly cited patents granted in artificial intelligence, machine learning, autonomy, and related advances, by selected region, country, or economy: 2010 and 2021ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-11Priority patent families granted in biotechnology, medical technology, genomics, and synthetic biology, by selected country or economy: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-12Utility patents granted in biotechnology, medical technology, genomics, and synthetic biology, by selected country or economy: 2024ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-13Highly cited patents granted in biotechnology, medical technology, genomics, and synthetic biology, by selected country or economy: 2010 and 2021ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-17Priority patent families granted in quantum information science and technology, by selected country or economy: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Figure TRN-19Highly cited patents granted in quantum information science and technology, by selected country or economy: 2010 and 2021ProviderProductEuropean Patent OfficePATSTAT
Table STRN-1U.S. federal and state agencies cited in the funding acknowledgement section of S&E articles, by citation frequency: 2002–22ProviderProductElsevierScopus
Table STRN-4Citations of S&E articles in USPTO utility patents, by cited field, cited author country, and patent sector: 2013–24ProviderProductElsevierScopus
Table STRN-5S&E articles with authors at federal agencies cited by granted U.S. patents, by author's affiliated agency: 2013–24ProviderProductElsevierScopus
Table STRN-15Priority patent families granted in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Table STRN-17Highly cited patents in artificial intelligence, machine learning, autonomy, and related advances for the top 20 most-patenting regions, countries, or economies: 2010–21ProviderProductEuropean Patent OfficePATSTAT
Table STRN-18Priority patent families granted in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Table STRN-20Highly cited patents in biotechnology, medical technology, genomics, and synthetic biology for the top 20 most-patenting regions, countries, or economies: 2010–21ProviderProductEuropean Patent OfficePATSTAT
Table STRN-21Priority patent families granted in semiconductors for the top 20 most-patenting regions, countries, or economies: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Table STRN-24Priority patent families granted in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Table STRN-26Highly cited patents in quantum information science and technology for the top 20 most-patenting regions, countries, or economies: 2010–21ProviderProductEuropean Patent OfficePATSTAT
Table STRN-27Priority patent families granted in advanced nuclear technologies for the top 20 most-patenting regions, countries, or economies: 2010–24ProviderProductEuropean Patent OfficePATSTAT
Table STRN-29Highly cited patents in advanced nuclear technologies for the top 20 most-patenting regions, countries, or economies: 2010–21ProviderProductEuropean Patent OfficePATSTAT
Table TRN-2U.S. federal agencies cited in the funding acknowledgement section of S&E articles, by citation frequency: 2002–22ProviderProductElsevierScopus
Table TRN-3U.S. federal agency activity in granted patents, S&E articles, and articles cited by patents, by inventor's or author's affiliated agency: 2013–24ProviderProductElsevierScopus